Arch Venture Partners V Llc - Net Worth and Insider Trading
Arch Venture Partners V Llc Net Worth
The estimated net worth of Arch Venture Partners V Llc is at least $33 Million dollars as of 2024-05-25. Arch Venture Partners V Llc is the 10% Owner of Alnylam Pharmaceuticals Inc and owns about 222,500 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $33 Million. Details can be seen in Arch Venture Partners V Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Arch Venture Partners V Llc has not made any transactions after 2004-05-27 and currently still holds the listed stock(s).
Transaction Summary of Arch Venture Partners V Llc
Arch Venture Partners V Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arch Venture Partners V Llc owns 3 companies in total, including Impinj Inc (PI) , NeurogesX Inc (NGSX) , and Alnylam Pharmaceuticals Inc (ALNY) .
Click here to see the complete history of Arch Venture Partners V Llc’s form 4 insider trades.
Insider Ownership Summary of Arch Venture Partners V Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PI | Impinj Inc | 2016-07-20 | 10 percent owner |
| NGSX | NeurogesX Inc | 2011-07-21 | 10 percent owner |
| ALNY | Alnylam Pharmaceuticals Inc | 2004-05-27 | 10 percent owner |
Arch Venture Partners V Llc Latest Holdings Summary
Arch Venture Partners V Llc currently owns a total of 1 stock. Arch Venture Partners V Llc owns 222,500 shares of Alnylam Pharmaceuticals Inc (ALNY) as of May 27, 2004, with a value of $33 Million.
Latest Holdings of Arch Venture Partners V Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2004-05-27 | 222,500 | 147.76 | 32,876,600 |
Holding Weightings of Arch Venture Partners V Llc
Arch Venture Partners V Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Arch Venture Partners V Llc has made a total of 0 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 0 shares on May 27, 2004, which brought Arch Venture Partners V Llc around $0.
Insider Trading History of Arch Venture Partners V Llc
- 1
Arch Venture Partners V Llc Trading Performance
Arch Venture Partners V Llc Ownership Network
Arch Venture Partners V Llc Owned Company Details
What does Impinj Inc do?
Who are the key executives at Impinj Inc?
Arch Venture Partners V Llc is the 10 percent owner of Impinj Inc. Other key executives at Impinj Inc include Chief Financial Officer Cary Baker , Chief Operating Officer Hussein Mecklai , and director & Chief Executive Officer Diorio Chris Ph.d. .
Impinj Inc (PI) Insider Trades Summary
Over the past 18 months, Arch Venture Partners V Llc made no insider transaction in Impinj Inc (PI). Other recent insider transactions involving Impinj Inc (PI) include a net sale of 71,016 shares made by Jeffrey Dossett , a net sale of 125,091 shares made by Diorio Chris Ph.d. , and a net sale of 70,340 shares made by Hussein Mecklai .
In summary, during the past 3 months, insiders sold 120,398 shares of Impinj Inc (PI) in total and bought 0 shares, with a net sale of 120,398 shares. During the past 18 months, 611,275 shares of Impinj Inc (PI) were sold and 1,627,591 shares were bought by its insiders, resulting in a net purchase of 1,016,316 shares.
Impinj Inc (PI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Impinj Inc Insider Transactions
Arch Venture Partners V Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Arch Venture Partners V Llc. You might contact Arch Venture Partners V Llc via mailing address: C/o Arch Venture Partners, 8755 W. Higgins Ave. #1025, Chicago Il 60631.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
